Therapy: Ustekinumab after anti-TNF failure: a step closer to the PSUMMIT of psoriatic arthritis therapy?

Nat Rev Rheumatol. 2014 Mar;10(3):125. doi: 10.1038/nrrheum.2014.24. Epub 2014 Feb 18.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Psoriatic / drug therapy*
  • Clinical Trials, Phase III as Topic
  • Humans
  • Treatment Failure
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Ustekinumab

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Ustekinumab